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Interstitial cells of Cajal (ICCs) in gastrointestinal tract are specialized cells serving as pacemaker cells. The origin of ICCs is
currently not fully characterized. In this work, we aimed to study whether bone marrow-derived cells (BMDCs) could contribute
to the origin of ICCs in the muscular plexus of small intestine using GFP-C57BL/6 chimeric mice.Engraftment of BMDCs
in the intestine was investigated for GFP expression. GFP positive bone marrow mononuclear cells reached a proportion of
95.65%±3.72%atdiﬀerenttimesinchimerism.Donor-derivedcellsdistributedwidelyinallthelayersofthegastrointestinaltract.
There were GFP positive BMDCs in the myenteric plexus, which resembled characteristics of ICCs, including myenteric location,
c-Kitpositivestaining,andramiﬁedmorphology.Donor-derivedICCsinthemyentericplexuscontributedtoapercentageranging
9.25% ± 4.9% of all the ICCs in the myenteric plexus. In conclusion, here we described that donor-derived BMDCs might
diﬀerentiate into gastrointestinal ICCs after radiation injury, which provided an alternative source for the origin of the ICCs in the
muscular plexus of adult intestine. These results further identiﬁed the plasticity of BMDCs and indicated therapeutic implications
of BMDCs for the gastrointestinal dysmotility caused by ICCs disorders.
1.Introduction
Interstitial cells of Cajal (ICCs) are the specialized cell popu-
lation of gastrointestinal cells, which perform essential roles
in regulating the motility of gastrointestinal tract. According
to their location in the intestine, ICCs could be divided
intofoursubgroups,includingsubmucosalICCs(ICCs-SM),
myenteric ICCs (ICCs-MY), intramuscular ICCs (ICCs-IM),
and deep muscular plexus ICCs (ICCs-DMP). ICCs-MY are
the most important population of ICCs in gastrointestinal
tract. ICCs express c-Kit, which is a kind of tyrosine kinase
receptor and at present widely used as the surface marker
of ICCs. The most obvious morphological characteristics
of them are that they usually possess processes and form
a network, which distinguish them from mast cells, the
other major c-Kit positive cells in the myenteric plexus
of GI tract. Therefore, it could be necessary to deﬁne the
gastrointestinal ICCs as a group of cells that have both
c-Kit expression and reticular morphological features [1].
Based on the current understanding of these cells, ICCs in
gastrointestinal tract mainly have four diﬀerent functions.
ICCs in the myenteric plexus are pacemaker cells, which
generatecharacteristicslowwavesspontaneously[2,3].They
mediate inputs from enteric nervous system to smooth
muscles. ICCs in the muscularis propria (ICCs-IM) have
been indicated to mediate neurotransmission, including
both the excitatory and inhibitory neuronal signals [4, 5].
They also perform as mechanosensors through sodium
channel on their membrane [6]. In addition, they could set
thesmoothmusclemembranepotentialgradient[7].Among
all these functions, the most important one is that they are
the pacemaker cells that generate characteristic slow waves
and regulate gastrointestinal motility.
As described above, ICCs are so important in regulating
thegastrointestinalfunctions.Anyhow,theyarealsosensitive
to harmful factors. For example, pulsating electromagnetic2 Journal of Biomedicine and Biotechnology
ﬁeld (PEMF) exposure would result in the loss of ICCs
[8]. It has also been reported that in several motility disor-
ders, such as achalasia, mechanical ileus, intestinal pseudo-
obstructions, or malformations, reduced number of ICCs or
dysfunction of their reticular structure could be observed [9,
10]. Recent studies indicate that intestinal surgical operation
would cause functional and morphological alterations of
ICCs in mice, including disrupted electrical rhythmicity,
neural responses, and interstitial cell networks [10].
During the past decades, it has been considered that
proliferation of ICCs could only be detected in embryonic
and neonatal periods. Recently, some investigators have
shown that there are proliferative ICCs in the myenteric
plexus after ICCs damage. For example, Mei et al. reported
that ICCs could regenerate and restore their normal
distribution after disruption by intestinal transection and
anastomosis [11]. These ﬁndings excite researchers to
explore the origin of ICCs.
Although the existence of ICCs has been identiﬁed for
several decades, the progenitors of ICCs are still mysterious.
At the beginning, ICCs had been presumed to be the descen-
dants of neural crest cells. Using chimeric model and devel-
opmentalobservation,itwasshownthatICCscamefromthe
mesenchyme of the gut, but not the neural crest. Common
precursors yielded ICCs-MY and longitudinal muscular
cells [12–14]. In the stomach of postnatal murine, a small
population of c-Kit
lowCD44+CD34+IGF
−IR+ cells had been
isolated and characterized. These cells resembled embryonic
ICCs precursors. And they could give rise to stomach ICCs
when they were stimulated by soluble stem cell factor (SCF)
andproducetypicalslow waveelectricity[15].Therefore,the
progenitors of ICCs might exist in the muscles of gastroin-
testinal tract. However, all these studies are carried out from
the developmental aspect. There are few reports concerning
the origin of ICCs in adulthood, and no other cell types have
been reported to have the ability to diﬀerentiate into ICCs.
Adult stem cells have been shown to have a great
potential of diﬀerentiation. Not all adult stem cells are
lineage restricted as previously believed. Among them,
bone marrow-derived cells (BMDCs) have the potential
to diﬀerentiate into several nonhematopoietic parenchymal
cells, including neurons, hepatocytes, cardiomyocytes, and
epithelial cells. Recently, BMDCs have been shown to
successfully accelerate burn wound healing and promote
the recovery of ischemic heart failure [16]. Therefore, it is
promising to exploit the wide diﬀerentiation potentiality of
BMDCs for the therapeutic treatment of human diseases. So
it is necessary to study whether multipotential stem cells in
othertissues,suchasBMDCs,couldbeenrolledandresidein
GI muscles and participate in the ICCs regeneration. In our
previous work, we had found that BMDCs could long term
repopulate the recipient’s gastrointestinal epithelium [17].
In the present study, we attempted to determine whether
BMDCs could diﬀerentiate into ICCs and contribute to
ICCs regeneration in gastrointestinal tract using a model of
GFP hematopoietic chimera. We found that BMDCs could
migrate into the myenteric plexus and diﬀerentiate into ICCs
in vivo after transplantation.
2.MaterialsandMethods
2.1. Animals. GFP-transgenic C57BL/6 mice were used
as transplantation donors and purchased from the
Model Animal Research Center of Nanjing University
(AAALAC accredited). The strain code was C57BL/6-
TgN(ActbEGFP)1Osb [18]. The expression level of EGFP
in bone marrow mononuclear cells was conﬁrmed by ﬂow
cytometry and laser confocal microscope analysis. The GFP
positive rate of BMDCs was more than 95%. Wild-type
C57BL/6 mice were used as transplantation recipients in
this study, which were 6∼8 weeks old and purchased from
Experimental Animals Center of Third Military Medical
University. All the animals were acclimated to standard
laboratory conditions (under a 12:12h light-dark cycle) and
kept in speciﬁc pathogen free (SPF) grade environment.
All animal experimental operations were conducted in
accordance with the Animal Care Guidelines of the Third
Military Medical University.
2.2. Bone Marrow Preparation. BMDCs of GFP transgenic
mice were prepared as described previously. Brieﬂy, bone
marrow was aseptically harvested from femurs and tibias of
donor mice by ﬂushing bone cavity with cold DMEM/F12
medium containing 10% fetal bovine serum (FBS) (Hyclone,
Beijing, China) using a syringe containing 100IU heparin
with a 20-gauge needle. Marrow samples were suﬃciently
pipetted, centrifuged, and then ﬁltered through a 20um
nylon mesh to expel dregs. Then red blood cells were splited
by RBC Lysis Buﬀer (8.26g ammonium chloride NH4Cl,
1g potassium bicarbonate KHCO3, and 0.037g EDTA in
1 liter ddH2O). All the marrow cells were resuspended
in DMEM/F12 without FBS. Cell viability was determined
by trypan blue exclusion experiment. About more than
95% harvested cells were viable. Then concentration of
BMDCs was determined by Beckman Coulter Z series
Counter (Beckman Coulter, Hialeah, FL). BMDCs were
resuspended in DMEM/F12 at a concentration of 1×107
viable nucleated cells per 350μL, a transplantation volume
for each recipient.
2.3. Irradiation and Transplantation. Forty C57BL/6 mice
were used as transplantation recipients in the experiment.
They were housed in autoclaved cages and treated with
antibiotics for 10 days before irradiation and 2 weeks after
irradiation (with 280mg erythromycin and 320mg gentam-
icin sulfate per liter of deionized drinking water). All the
recipient mice were exposed to 10 Gy whole body irradiation
(WBI) using a Cobalt-60 source (Theratron-780 model,
MDS Nordion, Ottawa, ON, Canada). Such an irradiation
dose had been used in many other transplantation studies
[19, 20] and would cause severe gastrointestinal symptoms,
such as diarrhea, bloody stool. Within three hours after
transplantation, ten female recipient mice received injection
of the same volume of PBS via tail vein as transplantation
control. The other thirty mice were transplanted via tail
vein with 1×107 GFP bone marrow cells in a volume of
350μL.Journal of Biomedicine and Biotechnology 3
2.4. Determination of Chimeric Model. In order to examine
the repopulation eﬀect, bone marrow of chimeric mice
was harvested as mentioned above. After depletion of RBC,
mononuclear cells were examined by confocal microscope
and ﬂow cytometry. Because positive cells expressed GFP
intrinsically, they were able to be recognized by 488nm
ﬂuorescence.
2.5. Tissue Preparations and Detection of Donor’s BMDCs.
Tissue sections or whole mount preparations of small intes-
tine were used for subsequent experiments. Fresh intestinal
samples were immediately immersed into liquid nitrogen or
ﬁxed with 4% paraformaldehyde (PFA) or 100% acetone.
Paraﬃn embedded intestinal samples were cut into 4um
sections. After dewaxing and rehydration, antigen retrieval
was carried out in 96
◦C for 10min using sodium citrate
solution(0.01M,pH6.0).Activityofendogenousperoxidase
was removed by incubation with 3% H2O2 for 15minutes at
room temperature, and nonspeciﬁc binding was blocked by
3% normal goat serum incubation for 30 min at room tem-
perature.Donor’sBMDCswereidentiﬁedbyrabbitanti-GFP
monoclonal antibody (1:200, AG279, Beyotime, Hangzhou,
China). Horseradish peroxidase- (HRP-) conjugated goat
antirabbit secondary antibody was used to bind the GFP
antibody. Positive signals were shown by DAB response.
Sections were counterstained with hematoxylin after IHC
reaction.
2.6. Detection of Donor Derived ICCs. ICCs were recognized
by c-Kit (ACK2, eBioscience, San Diego, CA, USA), and
macrophagesweredemonstratedusingratanti-F4/80mono-
clonalantibody(Abcam,Cambridge,MA,USA).Fluorescent
double staining was employed to detect coexpression of
GFP and c-Kit. Brieﬂy, frozen sections or whole mount
preparations were ﬁxed in cold acetone for 15min at 4◦C.
After this, the samples were rinsed in PBS for 10min.
Before adding primary antibody, nonspeciﬁc labeling was
blocked by incubation in PBS containing 10% normal goat
serum and 0.2% Triton X-100 at room temperature for
30min. Then they were incubated overnight at 4◦Cw i t h
primary antibody against c-Kit (1:100) or F4/80 (1:100).
After rinsing in PBS three times for suﬃcient washing,
Cy3-conjugated goat antirat secondary antibody (1:200)
was added. After 1h incubation in the dark and PBS
washing, GFP antibody (1:200) and FITC-conjugated goat
antirabbit secondary antibody (1:200) were sequentially
added and, respectively, incubated overnight at 4◦Ca n df o r
30 min at room temperature. After three times washing,
cell nuclei were counterstained with 0.3μM4  ,6-diamidino-
2-phenylindole, dihydrochloride (DAPI) (Molecular Probes,
Inc., Eugene, OR, USA) in PBS for 1min, which was done
at room temperature and in the dark. Digital images were
captured using TCS SP5 confocal laser scanning microscope
(Leica, Germany) with an excitation wavelength appropriate
for Cy3 (552nm) or FITC (488nm).
2.7. Statistics. SPSS version 16.0 (SPSS Inc., Chicago, USA)
was used to carry out all statistical analyses. Data were
Table 1 :T h ea v e r a g ep e r c e n t a g eo fG F Pp o s i t i v em a r r o wc e l l si n
recipient’s bone marrow (n = 3 at each point).
Time after transplantation GFP positive rate (%)
1 month 91.15±2.08
2 months 92.05±3.15
3 months 97.95±2.04
4 months 98.05±1.58
5 months 98.98±0.84
expressed as means ± SEM. Diﬀerences in the data were
evaluated by one-way analysis of variance (ANOVA). P <.05
was taken as a statistically signiﬁcant diﬀerence.
3. Results
3.1. Establishment of GFP Positive Chimera Model. Mice
transplanted with PBS in the control group died of bone
marrow failure and intestinal symptoms within 5∼7d a y s
after irradiation. On the other hand, all the mice in
transplantation group successfully underwent the ﬁrst week
after irradiation with a survival rate more than 93.3%. The
survival rate of these two groups had signiﬁcant diﬀerence
(P<. 05). Transplantation of BMDCs could eﬃciently
prevent recipients dying from bone marrow failure and gas-
trointestinal symptoms caused by irradiation. Bone marrow
of chimeric mice at second month after transplantation was
examined. Mononuclear cells in bone marrow were almost
completely replaced by GFP positive cells (Figure 1(a)). By
ﬂow cytometry analysis, a representative image of GFP
positive cells in all the marrow mononuclear cells at 2.5
monthswasshowninFigure 1(b).Chimericratesatdiﬀerent
timepoints were given in Table 1, and the average level was
95.65 %± 3.72%. The results indicated that the GFP positive
chimeric mice model was successfully established.
3.2. Engraftment of Donor’s BMDCs in Recipient’s Intestine.
Using immunohistochemistry (IHC), it was shown that
GFP positive BMDCs would migrate into intestine after
transplantation. BMDCs appeared in the submucosal lamina
propria during the ﬁrst week, and then the quantity of these
cells increased. There were positive cells in the muscular
layer of intestine. GFP positive cells could be observed in
the epithelium layer. Large amount of GFP positive BMDCs
fulﬁlled the mesenchymal region of intestine (Figure 2(a)).
Between the longitudinal and circular muscle cells, there
were GFP positive cells with the appearance of processes
(Figure 2(b), red arrow). The speciﬁcity of GFP antibody
was conﬁrmed by blank control staining. No positive signals
could be seen in the same section without GFP antibody
(Figure 2(c)). The muscular layer had been recovered from
the irradiation induced-damage. No signiﬁcant changes
could be observed through HE staining (Figure 2(d)).
3.3. Diﬀerentiation of BMDCs towards Macrophages in the
Muscular Layer. In order to examine the deﬁnite phenotype4 Journal of Biomedicine and Biotechnology
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Figure 1: Recipient’s bone marrow was reconstituted by transplantation of donor’s GFP positive BMDCs. (a) GFP positive marrow cells
took up the majority of chimeric bone marrow two months after transplantation. Bar= 50μm. (b) the percentage of GFP positive marrow
cells in chimeric marrow at two months after transplantation was shown to be 92.05% by ﬂow cytometry.
of GFP positive BMDCs in the muscular layer, macrophage
diﬀerentiation was ﬁrstly observed. Using the antibody
against F4/80, which was a widely-used surface marker for
macrophages, it was shown that there were certain GFP pos-
itive macrophages. But the majority of positive macrophages
were mainly found in the deep muscular plexus (DMP). For
example, at the second month, both GFP positive and F4/80
positive cells could be detected in the DMP layer (Lower
panel in Figure 3). GFP positive macrophages contributed
to a proportion of 50.92 ± 10.98% of all the macrophages
in the DMP layer. BMDCs contributed to the generation of
macrophages in DMP greatly.
3.4. Bone Marrow Derivation of ICCs-MY in Chimeric
Intestine. As mentioned above, GFP positive cells in the
DMP layer resembled macrophages appearance. We then
tried to observe the phenotype of BMDCs in the myenteric
plexus. In the myenteric plexus, GFP positive cells could
also be detected. c-Kit positive ICCs-MY were well demon-
strated using c-Kit antibody (ACK2). There were GFP and
ACK2 double positive cells both in the intestinal sections
and in the whole mount preparations. The representative
images were demonstrated in Figures 4 and 5,i nw h i c h
the images were taken from recipient intestine 2.5 months
after transplantation. Double positive cells were indicated
by arrow and enlarged in the inset (Merged image in the
lower panel of Figure 4). Donor-derived ICCs had bipolar
appearance on the whole mount preparations (white arrow
in merged image of the lower panel of Figure 5). Donor-
d e r i v e dI C C s - M Yr e a c h e dap r o p o r t i o no f9 . 2 5% ± 4.9%
among all the ICCs-MY in small intestine. These cells were
distributed along the intestine without region speciﬁcity.
Therefore, the transplanted BMDCs were able to engraft in
smooth muscle of small intestine and diﬀerentiate into ICCs
after the radiation injury.
4. Discussion
Adult stem cells exhibit more remarkable plasticity than
previously believed, and BMDCs could contribute to several
nonhematopoietic cell lineages. Both experimental and
clinic studies have demonstrated that donor’s BMDCs have
multipotential diﬀerentiation ability in various organs of
transplantation recipient, especially the nonhematopoietic
diﬀerentiation capacity. They could diﬀerentiated into
neurons, hepatocytes, and kidney tubular epithelial cells [21,Journal of Biomedicine and Biotechnology 5
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Figure 2: Detection of donor-derived BMDCs by GFP IHC in the small intestine 3 months after transplantation. (a) GFP positive BMDCs
could be integrated into any part of intestine. (b) donor-derived cells could also be observed between longitudinal muscle and circular
muscle, and there were some positive processes without ICCs body due to section reason (red arrow). (c) blank control without primary
antibody on the serial section. No positive signals could be detected. (d) HE staining of small intestine from transplanted mice.
22]. Among all these ﬁndings, Okamato et al reported that
BMDCs could also diﬀerentiate into epithelial cells to repop-
ulate the damaged intestinal epithelium [23, 24]. In the gas-
trointestinal tract, BMDCs have also been observed to diﬀer-
entiate into subepithelial myoﬁbroblasts, which are impor-
tant to regulate intestinal stem cell microenvironment [25].
Such exciting reports raised related research concerning the
eﬀects of BMDCs in regeneration of various injuries of gas-
trointestinal tract, such as dextran sulfate sodium (DSS) or
trinitrobenzenesulfonic acid-(TNBS-) induced IBD model
and alcohol-induced stomach epithelial injury [26–29]. All
these studies had shown that BMDCs could participate in
the injury restoration process in diﬀerent damage models.
In our experiments, we established the chimera model
using GFP transgenic mice. As conﬁrmed by both ﬂow
cytometry and confocal scanning, the bone marrow of
transplantation recipients had been repopulated by donor’s
BMDCs (Figure 1 and Table 1). In the previous study, we
found that GFP positive cells could for long term exist in
gastrointestinal tract. Because of ubiquitous GFP expression,
staining of GFP allowed us to detect the engraftment
and diﬀerentiation of donor-derived BMDCs conveniently.
GFP positive BMDCs engrafted into each segment of the
gastrointestinal tract without speciﬁcity. Besides epithelial
engraftment, there were certain GFP positive cells in the
tunica muscularis. For example, they could migrate into the
myenteric plexus and deep muscular plexus as shown in
Figure 2. Given the location of GFP positive cells, we tried to
explore the possibility that whether BMDCs could diﬀerenti-
ateintoICCsingastrointestinaltract.Macrophageshavealso
beenshowntoresidentinthemuscularlayer[30]. Therefore,
it was necessary for us to exclude whether these cells were
macrophages. Through GFP and F4/80 double staining, it
was demonstrated that GFP positive macrophages could be
detected deﬁnitely. Anyhow, these cells were mainly found in
the deep muscular plexus (Figure 3) and macrophages were
negative for c-Kit. Using frozen sections and whole mount
preparations, we found that there were GFP positive cells
with several branches, which resembled the morphological
characteristics of ICCs. In addition, GFP and c-Kit double
positive cells could be observed in the myenteric plexus
(Figures4and5).Thepositivecellshadatleasttwoprocesses,
which made them distinguishable from mast cells. Although
mast cells in the myenteric plexus were also positive for c-
Kit, these cells themselves were morphologically round and
without processes. Besides this, they were rarely observed
in the muscular layer of the mouse small intestine [31]. So
the double positive cells were ICCs-MY, but not mast cells
in the myenteric plexus. It encouraged us to believe that c-
Kit positive BMDCs in the myenteric plexus were intestinal
ICCs-MY according to the commonly accepted criteria,
including cell location, surface marker, and morphological
appearance.Therefore,thetransplantedBMDCswereableto
engraft in smooth muscle of intestine and diﬀerentiate into
ICCs after the radiation injury. At present, it was diﬃcult for
us to carry out electrophysiological studies to study whether
GFP positive cells could produce the slow wave electricity in
this chimeric model, but a recent study had reported that
bone marrow transplantation restored gut motility in Kit
deﬁcientmice[32],whichindicatedthatthesedonor-derived6 Journal of Biomedicine and Biotechnology
(μm)
05 0
(μm)
05 0 0
(μm)
50 05 0
(μm)
GFP F4/80 Overlay DAPI
C57 mouse
(μm)
07 5
(μm)
07 5 0
(μm)
75 50μm
Chimerism
Figure 3: Whole mount preparation of small intestine from both normal C57 mouse and chimeric mouse. in this ﬁgure, donor’s BMDCs
weredetectedbyGFPantibody.MacrophagesweredemonstratedbytheirspeciﬁcmarkerF4/80.Upperpanel:C57mousewasusedasnormal
control, in which all the macrophages were negative for GFP antibody. Bar= 50μm. Lower panel: in the chimerism some macrophages were
double positive for GFP and F4/80, suggesting that they were derived from the infused donor’s BMDCs. GFP+/F4/80+ cells were mainly
found at the deep myenteric plexus and they were scattered in this layer, which distinguished them from ICCs. Bar= 50μm.
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Figure 4: Confocal image of frozen section demonstrated donor derived ICCs-MY in small intestine of recipient mice 2.5 months after bone
marrow transplantation. Upper panel: C57 mouse was used as negative control, in which there were no GFP signals in the intestine. Lower
panel: In the chimerism, GFP and c-Kit double positive cells were shown in the merged image. Ampliﬁed image of interested cell was shown
as inset. Bar= 25μm.
ICCs played the same function as their wild-type mates. Liu
Dengqun and Wang Fengchao contributed equally to this
article.
Previous studies have demonstrated that ICCs originated
from mesenchymal cells, but not the neural crest cells
[13, 33]. The proliferation of ICCs and extension of the
processes are only observed in embryonic and neonatal
periods in mammals, and even ICCs isolated from 6-day
neonatal mice could not increase in number in vitro [34].
Recently, there were several investigations concerning the
plasticity of ICCs and loss and recovery of ICCs had been
reported [35, 36]. Proliferative ICCs that could incorporate
Brdu were observed after intestinal damage [37]. Another
recent study has successfully identiﬁed a very small groupJournal of Biomedicine and Biotechnology 7
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Figure 5: Representative immunoﬂuorescent image of GFP and c-Kit double positive ICCs on whole mount preparation of small intestine.
GFPproteinwasstainedbyFITC-labeledgoatantirabbitIgG,andc-KitwasdemonstratedbyCy3-conjugatedgoatanti-ratIgG.Upperpanel:
C57 mouse was used as negative control, in which there were no GFP signals in the intestine. Lower panel: GFP and c-Kit double positive
cells were shown in chimeric intestine. Double positive cells could be found on the whole mount preparation, indicating that ICCs could be
derived from BMDCs. Yellow arrow was indicated a double positive cell and white arrow directed to its two polar processes. Bar= 50μm.
of c-Kit
lowCD44+CD34+IGF-IR+ cells in murine stomach
as the putative progenitors of ICCs [15]. In the adult, the
transdiﬀerentiation of BMDCs has been well studied in
many transplantation models. It has been identiﬁed that
BMDCs are able to diﬀerentiate into adipocytes, osteocytes,
chondrocytes. In the gastrointestinal tract, BMDCs have
been reported to have the capacity to diﬀerentiate into
epithelial cells [17, 38]. In this study we used whole BMDCs
as transplantation graft and identiﬁed that they could
diﬀerentiate into ICCs. However, BMDCs used here were
cell mixtures without purifying speciﬁc bone marrow stem
cells (BMSCs). So we had not demonstrated that these ICCs
were derived from bone marrow stem cells. It was possible
that the GFP positive ICCs detected in the gut of recipients
could be derived from surviving trapped donor cells. Given
the current understanding of ICCs origin and characteristics
of mesenchymal stem cells (MSCs), we presumed that MSCs,
the most widely-investigated BMSCs, might be responsible
for the donor-derived ICCs after transplantation.
Previous studies had demonstrated that transplanted
BMDCs, such as MSCs, were preferentially recruited to the
injured tissues caused by ischemia, trauma, and disease and
could accelerate tissue regeneration. Herein, we conﬁrmed
the existence of transplanted bone marrow-derived ICCs
in small intestine several months after irradiation and
transplantation. It also meant that BMDCs as a source of
ICCs under physiological condition could not be completely
excluded. Because there were still GFP positive ICCs several
months later after the radiation injury and transplantation.
There were some other questions needed to be resolved in
further study. One question was how BMDCs, especially
BMSCs,suchasMSCs,coulddiﬀerentiateintoICCs.Because
only about 10% ICCs were donor-derived in the recipient’s
myenteric plexus, more eﬀorts to study the mechanisms for
BMDCs diﬀerentiation towards ICCs should be spent on
induction of BMDCs (especially MSCs) in vitro. Another
question was how to control the diﬀerentiation of BMDCs
t o w a r d sI C C sp r o p e r l y .I th a db e e nr e p o r t e dt h a ta b n o r m a l
ICCs might be the cause of gastrointestinal stromal tumors
(GISTs). Transformation of MSCs had also been reported
both in vivo and in vitro [39, 40]. Therefore, when MSCs
were used to repopulate ICCs damage, the safety was needed
to be taken into account.
Both transdiﬀerentiation and cell fusion have been used
to interpret the formation of donor-derived nonhematopoi-
etic cell phenotypes. Intestinal epithelial cells derived from
donor’s BMDCs were reported to be generated through
cell fusion between BMDCs and intestinal stem cells [41].
We had also performed Y-FISH and GFP IHC staining to
determinewhetherdonor-derivedICCsweretheproductsof
cell fusion phenomenon, but in our models we did not ﬁnd
occurrence of cell fusion between donor’s BMDCs and host’s
ICCs (unpublished data), suggesting that there was lack of
evidence of cell fusion in the formation process of donor
derived ICCs.
In conclusion, we showed that after irradiation and
transplantation donor’s BMDCs repopulated recipient
hematopoiesis, migrated into gastrointestinal tract, and had
thecapacitytodiﬀerentiateintoICCsinthemyentericplexus
in the present study. This suggests a new origin of ICCs
beyond gastrointestinal tract. All these results bring us a
novel insight into the plasticity of BMDCs and an alternative
cell resource for therapy of gastrointestinal dysmotility
caused by ICCs disorders. In the future the results need to be8 Journal of Biomedicine and Biotechnology
conﬁrmed using puriﬁed bone marrow stem cells to directly
demonstrate the origin of donor cells residing in the gut.
The speciﬁc formation mechanisms of donor-derived ICCs,
whether cell fusion or transdiﬀerentiation, might be further
investigated in the future.
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